134 related articles for article (PubMed ID: 11931623)
21. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
22. Highly selective iNOS inhibition and sphincter of Oddi motility in the Australian possum.
Sandstrom P; Woods CM; Brooke-Smith M; Saccone GT; Toouli J; Svanvik J
Acta Physiol Scand; 2004 Jul; 181(3):321-31. PubMed ID: 15196093
[TBL] [Abstract][Full Text] [Related]
23. Differential function of nitric oxide in murine antigen-induced arthritis.
Veihelmann A; Hofbauer A; Krombach F; Dorger M; Maier M; Refior HJ; Messmer K
Rheumatology (Oxford); 2002 May; 41(5):509-17. PubMed ID: 12011373
[TBL] [Abstract][Full Text] [Related]
24. 5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors.
Hallinan EA; Hagen TJ; Bergmanis A; Moore WM; Jerome GM; Spangler DP; Stevens AM; Shieh HS; Manning PT; Pitzele BS
J Med Chem; 2004 Feb; 47(4):900-6. PubMed ID: 14761191
[TBL] [Abstract][Full Text] [Related]
25. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
[TBL] [Abstract][Full Text] [Related]
26. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine.
Walker LM; Walker PD; Imam SZ; Ali SF; Mayeux PR
J Pharmacol Exp Ther; 2000 Oct; 295(1):417-22. PubMed ID: 10992009
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
[TBL] [Abstract][Full Text] [Related]
28. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.
Moore WM; Webber RK; Jerome GM; Tjoeng FS; Misko TP; Currie MG
J Med Chem; 1994 Nov; 37(23):3886-8. PubMed ID: 7525961
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats.
Fletcher DS; Widmer WR; Luell S; Christen A; Orevillo C; Shah S; Visco D
J Pharmacol Exp Ther; 1998 Feb; 284(2):714-21. PubMed ID: 9454819
[TBL] [Abstract][Full Text] [Related]
30. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
[TBL] [Abstract][Full Text] [Related]
31. Urinary nitrate excretion in cholesterol-fed rabbits: effect of a chronic treatment by N-iminoethyl-L-lysine, a selective inhibitor of inducible nitric oxide synthase.
Behr-Roussel D; Rupin A; Simonet S; Fabiani J; Verbeuren TJ
Eur J Pharmacol; 2000 Feb; 388(3):275-9. PubMed ID: 10675737
[TBL] [Abstract][Full Text] [Related]
32. L-N6-(1-iminoethyl)-lysine (L-NIL) but not S-methylisothiourea sulphate (SMT) displays selectivity towards NOS-2.
Chłopicki S; Olszanecki R; Jakubowski A; Lomnicka M; Gryglewski RJ
Pol J Pharmacol; 1999; 51(5):443-7. PubMed ID: 10817546
[TBL] [Abstract][Full Text] [Related]
33. Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats.
Asakura H; Asamura R; Ontachi Y; Hayashi T; Yamazaki M; Morishita E; Miyamoto KI; Nakao S
J Thromb Haemost; 2005 May; 3(5):1050-5. PubMed ID: 15869603
[TBL] [Abstract][Full Text] [Related]
34. Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection.
Pieper GM; Nilakantan V; Hilton G; Zhou X; Khanna AK; Halligan NL; Felix CC; Kampalath B; Griffith OW; Hayward MA; Roza AM; Adams MB
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H525-34. PubMed ID: 14715498
[TBL] [Abstract][Full Text] [Related]
35. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia.
Matejovic M; Krouzecky A; Martinkova V; Rokyta R; Kralova H; Treska V; Radermacher P; Novak I
Shock; 2004 May; 21(5):458-65. PubMed ID: 15087823
[TBL] [Abstract][Full Text] [Related]
36. Effects of NO synthase inhibitors on the synovial microcirculation in the mouse knee joint.
Veihelmann A; Krombach F; Refior HJ; Messmer K
J Vasc Res; 1999; 36(5):379-84. PubMed ID: 10559678
[TBL] [Abstract][Full Text] [Related]
37. Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human beta2 microglobulin transgenic rats.
Blanchard HS; Dernis-Labous E; Lamarque D; Nhieu JT; Szepes Z; Fléjou JF; Wollman E; Whittle BJ; Breban M
Eur Cytokine Netw; 2001 Mar; 12(1):111-8. PubMed ID: 11282554
[TBL] [Abstract][Full Text] [Related]
38. The modulation of hepatic injury and heat shock expression by inhibition of inducible nitric oxide synthase after hemorrhagic shock.
Menezes JM; Hierholzer C; Watkins SC; Billiar TR; Peitzman AB; Harbrecht BG
Shock; 2002 Jan; 17(1):13-8. PubMed ID: 11795663
[TBL] [Abstract][Full Text] [Related]
39. Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally-induced septic shock in rats.
Kadoi Y; Goto F
Anesth Analg; 2004 Jul; 99(1):212-220. PubMed ID: 15281532
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
